Skip to content

Efficacy and safety of the Dermatological Soap with ozonated sunflower oil (AGO), or with sulfur, or with sulfur+AGO and Cream with AGO in patients with Scabies.

Evaluation of the efficacy and safety of Dermatological Soap with AGO, or with sulfur, or with sulfur+AGO and Cream with AGO in patients with Scabies. - AGO-ESCABIOSIS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
RPCEC
Registry ID
RPCEC00000439
Enrollment
75
Registered
2024-04-16
Start date
2024-09-02
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scabies

Interventions

Group 1 (Experimental): Dermatological soap with AGO + Cream with AGO. The soap will be used for daily bathing in the afternon and then applyng the cream, topically, from the neck down, scalp and ear

Sponsors

National Centre for Scientific Research (CNIC)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with confirmed scabies, of both sexes, 19 years or older, who present itching mainly at night and the presence of skin lesions, who agree to participate in the study after signing their informed consent.

Exclusion criteria

Exclusion criteria: Patients with: 1. Skin lesions with added infection 2. Known hypersensitivity to the products to be used 3. Other skin lesions already diagnosed 4. Moderate-severe cognitive disorders

Design outcomes

Primary

MeasureTime frame
1. Cure clinical (absence of itching and skin lesions ) or clinical improvement (improvement of itching and skin lesions). Measurement time: 7, 14 and 21 days of treatment. 2. Negativization of Dermatoscopy (Positive, Negative). Measurement time: 21 days of treatment.

Secondary

MeasureTime frame
1. EASI Scale (Eczema Area and Severity Index). Measurement time: At baseline and, 7, 14 and 21 days of treatment. 2. VAS Scale (Visual analogical scale). Measurement time: At baseline and, 7, 14 and 21 days of treatment. 3. Quality of Life Questionnaire (EuroQol). Measurement time: At baseline and, 7, 14 and 21 days of treatment.

Countries

Cuba

Contacts

Public ContactThuyen Fong Fernandez

10 de Octubre Clinical Surgical Teaching Hospital

thuyen.fong@infomed.sld.cu

Outcome results

None listed

Source: RPCEC (via WHO ICTRP) · Data processed: Aug 25, 2026